2型心肌梗死氧供需失衡因素与结局评估:High-STEACS整群随机临床试验二次分析
该研究为High-STEACS阶梯楔形整群随机临床试验的二次分析,在苏格兰10家二级和三级医院纳入2013年6月10日至2016年3月3日连续疑似急性冠脉综合征患者,按第四版心肌梗死通用定义裁定1型或2型心梗,共6096例(女性2602例[43%],中位年龄70岁[IQR 58-80岁]),其中1型心梗4981例、2型心梗1115例。2型心梗最常见的氧供需失衡因素为快速性心律失常(616/1115[55%]),其次为低氧血症(219/1115[20%])、贫血(95/1115[9%])、低血压(89/1115[8%])、重度高血压(61/1115[5%])和冠状动脉机制(35/1115[3%])。1年全因死亡在1型心梗为15%(720/4981)、2型心梗为23%(285/1115);与1型心梗相比,低氧血症所致2型心梗(aOR 2.35;95%CI 1.72-3.18)和贫血所致2型心梗(aOR 1.83;95%CI 1.14-2.88)死亡风险最高,快速性心律失常所致(aOR 0.83;95%CI 0.65-1.06)和冠状动脉机制所致(aOR 1.07;95%CI 0.17-3.86)死亡风险与1型心梗相近。作者认为临床医生在决定哪些病例需要管理时应考虑这些差异结局。
要点
- 2型心梗1年全因死亡23%(285/1115),高于1型心梗的15%(720/4981)。
- 低氧血症所致2型心梗死亡风险最高:aOR 2.35(95%CI 1.72-3.18),约为1型心梗2倍。
- 贫血所致2型心梗aOR 1.83(95%CI 1.14-2.88),死亡风险亦高于1型心梗。
- 快速性心律失常占2型心梗55%(616/1115),aOR 0.83(95%CI 0.65-1.06),与1型心梗风险相近。
- 低氧血症和贫血合计约占2型心梗1/3,是死亡风险最高的亚组。
适用人群与场景
- 苏格兰10家二级和三级医院连续纳入的疑似急性冠脉综合征患者,经裁定诊断为1型或2型心肌梗死(共6096例,女性2602例[43%],中位年龄70岁[IQR 58-80岁])。
- 2型心肌梗死定义为与心肌氧供需失衡主要因素相关的类型,按第四版心肌梗死通用定义裁定。
诊断标准与关键阈值
- 心肌梗死诊断依据第四版心肌梗死通用定义裁定,并定义2型心梗中与氧供需失衡相关的主要因素。
- 氧供需失衡因素分类:快速性心律失常、低氧血症、贫血、低血压、重度高血压、冠状动脉机制。
红旗征与不能漏的情况
- 低氧血症所致2型心梗:1年死亡风险约为1型心梗的2倍(aOR 2.35;95%CI 1.72-3.18),为死亡风险最高的亚组。
- 贫血所致2型心梗:1年死亡风险高于1型心梗(aOR 1.83;95%CI 1.14-2.88)。
研究设计与关键结果
- 研究类型:阶梯楔形整群随机临床试验(High-STEACS)的二次分析,在苏格兰10家二级和三级医院进行,纳入6096例裁定为1型或2型心肌梗死的患者(1型4981例,2型1115例),干预为实施高敏心肌肌钙蛋白I检测;该二次分析非预先设定。
- 2型心梗氧供需失衡因素分布:快速性心律失常616/1115(55%)、低氧血症219/1115(20%)、贫血95/1115(9%)、低血压89/1115(8%)、重度高血压61/1115(5%)、冠状动脉机制35/1115(3%)。
- 1年全因死亡:1型心梗15%(720/4981),2型心梗23%(285/1115)。
- 与1型心梗相比,低氧血症所致2型心梗死亡aOR 2.35(95%CI 1.72-3.18),贫血所致2型心梗aOR 1.83(95%CI 1.14-2.88)。
- 与1型心梗相比,快速性心律失常所致2型心梗死亡aOR 0.83(95%CI 0.65-1.06),冠状动脉机制所致aOR 1.07(95%CI 0.17-3.86)。
证据类型、等级与局限
- 证据类型:随机临床试验(阶梯楔形整群随机)的二次分析;二次分析非预先设定。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,临床医生在决定哪些2型心梗病例需要管理时应考虑氧供需失衡病因相关的差异结局,以改善患者结局。
- 低氧血症和贫血所致2型心梗死亡风险约为1型心梗的2倍,快速性心律失常所致者预后较好、与1型心梗相近。
指南或共识出处
- High-STEACS整群随机临床试验(ClinicalTrials.gov标识NCT01852123)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Type 2 myocardial infarction occurs owing to multiple factors associated with myocardial oxygen supply-demand imbalance, which may confer different risks of adverse outcomes.
OBJECTIVE: To evaluate the prevalence and outcomes of different factors associated with oxygen supply-demand imbalance among patients with type 2 myocardial infarction.
DESIGN, SETTING, AND PARTICIPANTS: In this secondary analysis of a stepped-wedge, cluster randomized clinical trial conducted at 10 secondary and tertiary care hospitals in Scotland, 6096 patients with an adjudicated diagnosis of type 1 or type 2 myocardial infarction from June 10, 2013, to March 3, 2016, were identified, and the findings were reported on August 28, 2018. The trial enrolled consecutive patients with suspected acute coronary syndrome. The diagnosis of myocardial infarction was adjudicated according to the Fourth Universal Definition of Myocardial Infarction and the primary factor associated with oxygen supply-demand imbalance in type 2 myocardial infarction was defined. This secondary analysis was not prespecified. Statistical analysis was performed from July 7 to 30, 2020.
INTERVENTION: Implementation of a high-sensitivity cardiac troponin I assay.
MAIN OUTCOMES AND MEASURES: All-cause death at 1 year according to the factors associated with oxygen supply-demand imbalance among patients with type 2 myocardial infarction.
RESULTS: Of 6096 patients (2602 women [43%]; median age, 70 years [IQR, 58-80 years]), 4981 patients had type 1 myocardial infarction, and 1115 patients had type 2 myocardial infarction. The most common factor associated with oxygen supply-demand imbalance was tachyarrhythmia (616 of 1115 [55%]), followed by hypoxemia (219 of 1115 [20%]), anemia (95 of 1115 [9%]), hypotension (89 of 1115 [8%]), severe hypertension (61 of 1115 [5%]), and coronary mechanisms (35 of 1115 [3%]). At 1 year, all-cause mortality occurred for 15% of patients (720 of 4981) with type 1 myocardial infarction and 23% of patients (285 of 1115) with type 2 myocardial infarction. Compared with patients with type 1 myocardial infarction, those with type 2 myocardial infarction owing to hypoxemia (adjusted odds ratio [aOR], 2.35; 95% CI, 1.72-3.18) and anemia (aOR, 1.83; 95% CI, 1.14-2.88) were at greatest risk of death, whereas those with type 2 myocardial infarction owing to tachyarrhythmia (aOR, 0.83; 95% CI, 0.65-1.06) or coronary mechanisms (aOR, 1.07; 95% CI, 0.17-3.86) were at similar risk of death as patients with type 1 myocardial infarction.
CONCLUSIONS AND RELEVANCE: In this secondary analysis of a randomized clinical trial, mortality after type 2 myocardial infarction was associated with the underlying etiologic factor associated with oxygen supply-demand imbalance. Most type 2 myocardial infarctions were associated with tachyarrhythmia, with better prognosis, whereas hypoxemia and anemia accounted for one-third of cases, with double the mortality of type 1 myocardial infarction. These differential outcomes should be considered by clinicians when determining which cases need to be managed if patient outcomes are to improve.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01852123.
参考来源
- Bularga A, Taggart C, Mendusic F, et al. Assessment of Oxygen Supply-Demand Imbalance and Outcomes Among Patients With Type 2 Myocardial Infarction: A Secondary Analysis of the High-STEACS Cluster Randomized Clinical Trial. JAMA Netw Open. 2022. PMID: 35816305. doi:10.1001/jamanetworkopen.2022.20162
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。